Quanterix Execs to Present at Canaccord Growth Conference
Event summary
- Quanterix execs to participate in Canaccord Growth Conference Aug. 11-12, 2026.
- CEO Everett Cunningham to host fireside chat on strategic priorities Aug. 12 at 1:00 PM ET.
- CTO Michael Miller to join neurology diagnostics panel discussion Aug. 12 at 2:00 PM ET.
- One-on-one investor meetings scheduled with CEO, CFO Jason Faessler, and CTO.
The big picture
Quanterix's participation in the Canaccord Growth Conference underscores its push to strengthen investor relations and showcase its precision biomarker technology. The focus on neurology diagnostics aligns with broader industry trends toward early disease detection and personalized medicine, where Quanterix aims to differentiate itself through high-sensitivity biomarker analysis.
What we're watching
- Strategic Priorities
- How Quanterix will articulate its growth strategy under CEO Cunningham's leadership.
- Market Positioning
- Whether the integration of Akoya Biosciences will enhance Quanterix's competitive edge in neurology diagnostics.
- Investor Sentiment
- The pace at which investor interest translates into tangible partnerships or deals post-conference.
Related topics